Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
4
×
clinical trials
fda
boston blog main
boston top stories
eli lilly
national
new york blog main
san francisco blog main
san francisco top stories
abbvie
abcellera
aimmune therapeutics
allergan
allergy
amgen
anaphylaxis
andrew oxtoby
antibodies
biofourmis
biohaven
biovotion
boston
boulder/denver blog main
boulder/denver top stories
cgpr
chugai pharmaceutical
coronavirus
covid-19
daniel edelman
deals
detroit blog main
detroit top stories
drug discovery
edbi
eosinophilic esophagitis
europe blog main
What
treat
4
×
approved
fda
medicines
therapeutics
abcellera
abcellera’s
adults
agency
aimmune
allergan
allergy
analytics
antibodies
antibody
approval
awarded
based
biofourmis
biologics
biotech
class
coronavirus
data
developed
devices
digital
drug
employs
enter
friday
globally
hauls
help
identified
immunotherapy
late
leads
migraine
million
Language
unset
4
×
Current search:
treat
×
unset
×
" national top stories "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
